1. Simultaneous measurement of hundreds of liver proteins: application in assessment of liver function
- Author
-
N. Leigh Anderson, Norman G. Anderson, Jean-Paul Hofmann, Ricardo Esquer-Blasco, John Taylor, and Susan Swift
- Subjects
040301 veterinary sciences ,04 agricultural and veterinary sciences ,Cell Biology ,Computational biology ,Biology ,Toxicology ,Bioinformatics ,030226 pharmacology & pharmacy ,Pathology and Forensic Medicine ,0403 veterinary science ,03 medical and health sciences ,Structure-Activity Relationship ,0302 clinical medicine ,Molecular level ,Protein mapping ,Liver ,Liver Function Tests ,Two dimensional electrophoresis ,Animals ,Humans ,Electrophoresis, Gel, Two-Dimensional ,Liver function ,Molecular Biology - Abstract
Proteins implement most biological functions at the molecular level. As one might expect based on this fact, it appears that the altered functional states associated with toxic effects involve changes in the abundance or structure of proteins. Although numerous specific assays exist to measure changes in the abundance of individual proteins, practical limitations have prevented widespread use of multiple protein assays for the global characterization of toxicity. Recent developments in protein analytical technology are rapidly changing this picture. Two-dimensional gel electrophoresis, a technique capable of resolving and quantitating hundreds of proteins simultaneously, is becoming an automated, high-throughput tool. In parallel, techniques have been developed that allow the resulting deluge of protein measurements to be organized into a prototype Molecular Effects Database™ describing xenobiotic effects in rodent liver. This database can detect, classify, and characterize a broad range of liver toxicity mechanisms. It currently contains approximately 10 million protein measurements, including data on the liver effects of 43 compounds, with a further 50 compounds to be added in 1995. Observed effects range from very broad (sex steroids alter levels of 45% of all liver proteins) to very specific (e.g., hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors). Companion 2-dimensional databases describing rodent brain and kidney have been initiated, as have linkages to the genomic sequence databases. Assimilation of this approach into research and regulatory toxicology poses an interesting challenge—one that is likely to lead to a radically more sophisticated understanding of toxicity and its biological basis.
- Published
- 1996